Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Prostate Cancer (mCRPC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04629781
What this trial is testing

Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Swiss Cancer Institute 11
Testing effectiveness (Phase 2)Ended earlyNCT04631601
What this trial is testing

Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 55
Testing effectiveness (Phase 2)UnknownNCT03700099
What this trial is testing

Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Instituto do Cancer do Estado de São Paulo 30
Early research (Phase 1)Study completedNCT03822871
What this trial is testing

A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Cancer Targeted Technology 17
Not applicableLooking for participantsNCT07118436
What this trial is testing

Liquid Biopsy Under PSMA Radioligand Therapy

Who this might be right for
Prostate Cancer Metastatic Castration-ResistantProstate Cancer
Wuerzburg University Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05067140
What this trial is testing

ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Novartis Pharmaceuticals 164
Not applicableStudy completedNCT04000776
What this trial is testing

3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Université de Sherbrooke 100
Very early researchNot Yet RecruitingNCT07609225
What this trial is testing

Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
University of Wisconsin, Madison 15
Early research (Phase 1)Active Not RecruitingNCT06052306
What this trial is testing

Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Bayer 232
Testing effectiveness (Phase 2)Ended earlyNCT01385293
What this trial is testing

BKM120 in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerMetastatic (Spread to Other Areas of the Body)
Andrew J. Armstrong, MD 30
Testing effectiveness (Phase 2)Looking for participantsNCT04986423
What this trial is testing

ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Zenith Epigenetics 200
Very early researchNot Yet RecruitingNCT07381582
What this trial is testing

Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer
Peking Union Medical College Hospital 15
Early research (Phase 1)Looking for participantsNCT06193486
What this trial is testing

Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 30
Testing effectiveness (Phase 2)Study completedNCT04495179
What this trial is testing

AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.

Who this might be right for
Progressive Metastatic Castrate-Resistant Prostate Cancer
AstraZeneca 30
Testing effectiveness (Phase 2)Study completedNCT01867710
What this trial is testing

Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy

Who this might be right for
Prostate Cancer
Janssen Pharmaceutica N.V., Belgium 164
Early research (Phase 1)WithdrawnNCT03110588
What this trial is testing

Phase I Trial of PACE for Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
University of Alabama at Birmingham
Post-approval studies (Phase 4)Study completedNCT03641560
What this trial is testing

A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma Inc 52
Early research (Phase 1)Looking for participantsNCT07103018
What this trial is testing

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Castration-Resistant Prostate Cancer PatientsMetastatic Castration-resistant Prostate Cancer, mCRPC+2 more
K36 Therapeutics, Inc. 144
Testing effectiveness (Phase 2)Looking for participantsNCT05168618
What this trial is testing

Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
University of Utah 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT02861573
What this trial is testing

Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Merck Sharp & Dohme LLC 1,200
Next Page